A cost-utility analysis of lumbar decompression with and without fusion for degenerative spine disease in the elderly

Neurosurgery

Volumn 77, Issue 4, 2015, Pages S116-S124

  Devin, Clinton J ^a   Chotai, Silky ^a   Parker, Scott L ^a   Tetreault, Lindsay ^b   Fehlings, Michael G ^b   McGirt, Matthew J ^c  

^a VANDERBILT UNIVERSITY   (United States)

^b TORONTO WESTERN HOSPITAL   (Canada)

^c CAROLINA NEUROSURGERY AND SPINE ASSOCIATES   (United States)

Author keywords

Cost; Cost utility; Cost effectiveness; Decompression; Elderly; Fusion; Lumbar; QALY

Indexed keywords

OPIATE;

AGED; ARTICLE; BACKACHE; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DEGENERATIVE DISEASE; DISABILITY; DRUG USE; FEMALE; GERIATRIC PATIENT; GROUPS BY AGE; HUMAN; LEG PAIN; LENGTH OF STAY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; SPINAL CORD DECOMPRESSION; SPINE DISEASE; TREATMENT OUTCOME; WORKING TIME; AGE; COST BENEFIT ANALYSIS; DECOMPRESSION SURGERY; ECONOMICS; LUMBAR VERTEBRA; MEDICARE; MIDDLE AGED; PROCEDURES; REGISTER; SPINE FUSION; SPONDYLOSIS; UNITED STATES;

AGE FACTORS; AGED; COST-BENEFIT ANALYSIS; DECOMPRESSION, SURGICAL; FEMALE; HUMANS; LONGITUDINAL STUDIES; LUMBAR VERTEBRAE; MALE; MEDICARE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; REGISTRIES; SPINAL FUSION; SPONDYLOSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 84941891900     PISSN: 0148396X     EISSN: 15244040     Source Type: Journal    
DOI: 10.1227/NEU.0000000000000949     Document Type: Article

References (48)

1. Dagenais S, Caro J, Haldeman S. A systematic review of low back pain cost of illness studies in the United States and internationally. Spine J. 2008;8(1):8-20.
2. Deyo RA, Mirza SK, Martin BI, Kreuter W, Goodman DC, Jarvik JG. Trends, major medical complications, and charges associated with surgery for lumbar spinal stenosis in older adults. JAMA. 2010;303(13):1259-1265.
3. Luo X, Pietrobon R, Sun SX, Liu GG, Hey L. Estimates and patterns of direct health care expenditures among individuals with back pain in the United States. Spine (Phila Pa 1976). 2004;29(1):79-86.
4. Waterman BR, Belmont PJ Jr, Schoenfeld AJ. Low back pain in the United States: incidence and risk factors for presentation in the emergency setting. Spine J. 2012;12(1):63-70.
5. Weinstein JN, Lurie JD, Olson PR, Bronner KK, Fisher ES. United States' trends and regional variations in lumbar spine surgery: 1992-2003. Spine (Phila Pa 1976). 2006;31(23):2707-2714.
6. Emanuel EJ, Fuchs VR. The perfect storm of overutilization. JAMA. 2008;299(23):2789-2791.
7. Larkin DJ, Swanson RC, Fuller S, Cortese DA. The Affordable Care Act: a case study for understanding and applying complexity concepts to health care reform [published online ahead of print November 4, 2014]. J Eval Clin Pract. doi: 10.1111/jep. 12271. Available at: http://onlinelibrary.wiley.com/doi/10.1111/jep. 12271/full. Accessed August 11, 2015.
8. Phillips KA, Hotlgrave DR. Using cost-effectiveness/cost-benefit analysis to allocate health resources: a level playing field for prevention? Am J Prev Med. 1997;13(1):18-25.
9. Smith WF. Cost-effectiveness and cost-benefit analyses for public health programs. Public Health Rep. 1968;83(11):899-906.
10. Gellman DD. Cost-benefit in health care: we need to know much more. Can Med Assoc J. 1974;111(9):988-989.
11. Dagenais S, Roffey DM, Wai EK, Haldeman S, Caro J. Can cost utility evaluations inform decision making about interventions for low back pain? Spine J. 2009;9(11):944-957.
12. Tosteson AN, Lurie JD, Tosteson TD, et al. Surgical treatment of spinal stenosis with and without degenerative spondylolisthesis: cost-effectiveness after 2 years. Ann Intern Med. 2008;149(12):845-853.
13. Katz JN, Lipson SJ, Lew RA, et al. Lumbar laminectomy alone or with instrumented or noninstrumented arthrodesis in degenerative lumbar spinal stenosis: patient selection, costs, and surgical outcomes. Spine (Phila Pa 1976). 1997;22(10):1123-1131.
14. Soegaard R, Christensen FB. Health economic evaluation in lumbar spinal fusion: a systematic literature review anno 2005. Eur Spine J. 2006;15(8):1165-1173.
15. Rihn JA, Currier BL, Phillips FM, Glassman SD, Albert TJ. Defining the value of spine care. J Am Acad Ortho Surg. 2013;21(7):419-426.
16. Hansson E, Hansson T. The cost-utility of lumbar disc herniation surgery. Eur Spine J. 2007;16(3):329-337.
17. Kim S, Mortaz Hedjri S, Coyte PC, Rampersaud YR. Cost-utility of lumbar decompression with or without fusion for patients with symptomatic degenerative lumbar spondylolisthesis. Spine J. 2012;12(1):44-54.
18. Harrop JS, Hilibrand A, Mihalovich KE, Dettori JR, Chapman J. Costeffectiveness of surgical treatment for degenerative spondylolisthesis and spinal stenosis. Spine (Phila Pa 1976). 2014;39(22 suppl 1):S75-S85.
19. Parker SL, Fulchiero EC, Davis BJ, et al. Cost-effectiveness of multilevel hemilaminectomy for lumbar stenosis-associated radiculopathy. Spine J. 2011;11(8):705-711.
20. Parker SL, Adogwa O, Bydon A, Cheng J, McGirt MJ. Cost-effectiveness of minimally invasive versus open transforaminal lumbar interbody fusion for degenerative spondylolisthesis associated low-back and leg pain over two years. World Neurosurg. 2012;78(1-2):178-184.
21. Kuntz KM, Snider RK, Weinstein JN, Pope MH, Katz JN. Cost-effectiveness of fusion with and without instrumentation for patients with degenerative spondylolisthesis and spinal stenosis. Spine (Phila Pa 1976). 2000;25(9):1132-1139.
22. Ghogawala Z, Whitmore RG, Watters WC III, et al. Guideline update for the performance of fusion procedures for degenerative disease of the lumbar spine, part 3: assessment of economic outcome. J Neurosurg Spine. 2014;21(1):14-22.
23. Fairbank JC, Pynsent PB. The Oswestry Disability Index. Spine (Phila Pa 1976). 2000;25(22):2940-2952; discussion 2952.
24. EuroQol Group. EuroQol: a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199-208.
25. Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220-233.
26. Langley GB, Sheppeard H. The visual analogue scale: its use in pain measurement. Rheumatol Int. 1985;5(4):145-148.
27. Copay AG, Glassman SD, Subach BR, Berven S, Schuler TC, Carreon LY. Minimum clinically important difference in lumbar spine surgery patients: a choice of methods using the Oswestry Disability Index, Medical Outcomes Study questionnaire Short Form 36, and pain scales. Spine J. 2008;8(6):968-974.
28. Parker SL, Adogwa O, Paul AR, et al. Utility of minimum clinically important difference in assessing pain, disability, and health state after transforaminal lumbar interbody fusion for degenerative lumbar spondylolisthesis. J Neurosurg Spine. 2011;14(5):598-604.
29. Parker SL, Godil SS, Shau DN, Mendenhall SK, McGirt MJ. Assessment of the minimum clinically important difference in pain, disability, and quality of life after anterior cervical discectomy and fusion: clinical article. J Neurosurg Spine. 2013;18(2):154-160.
30. Adogwa O, Parker SL, Shau DN, et al. Cost per quality-adjusted life year gained of revision neural decompression and instrumented fusion for same-level recurrent lumbar stenosis: defining the value of surgical intervention. J Neurosurg Spine. 2012;16(2):135-140.
31. Adogwa O, Parker SL, Shau DN, et al. Cost per quality-adjusted life year gained of laminectomy and extension of instrumented fusion for adjacent-segment disease: defining the value of surgical intervention. J Neurosurg Spine. 2012;16(2):141-146.
32. Bala MM, Riemsma RP, Nixon J, Kleijnen J. Systematic review of the (cost-) effectiveness of spinal cord stimulation for people with failed back surgery syndrome. Clin J Pain. 2008;24(9):741-756.
33. Weinstein JN, Tosteson TD, Lurie JD, et al. Surgical versus nonsurgical therapy for lumbar spinal stenosis. N Engl J Med. 2008;358(8):794-810.
34. Obradovic M, Lal A, Liedgens H. Validity and responsiveness of EuroQol-5 dimension (EQ-5D) versus Short Form-6 dimension (SF-6D) questionnaire in chronic pain. Health Qual Life Outcomes. 2013;11:110.
35. Jakola AS, Sorlie A, Gulati S, Nygaard OP, Lydersen S, Solberg T. Clinical outcomes and safety assessment in elderly patients undergoing decompressive laminectomy for lumbar spinal stenosis: a prospective study. BMC Surg. 2010;10:34.
36. Ragab AA, Fye MA, Bohlman HH. Surgery of the lumbar spine for spinal stenosis in 118 patients 70 years of age or older. Spine (Phila Pa 1976). 2003;28(4):348-353.
37. Martin BI, Mirza SK, Comstock BA, Gray DT, Kreuter W, Deyo RA. Reoperation rates following lumbar spine surgery and the influence of spinal fusion procedures. Spine (Phila Pa 1976). 2007;32(3):382-387.
38. Sato S, Yagi M, Machida M, et al. Reoperation rate and risk factors of elective spinal surgery for degenerative spondylolisthesis: minimum 5-year follow-up. Spine J. 2015;15(7):1536-1544.
39. Tso P, Walker K, Mahomed N, Coyte PC, Rampersaud YR. Comparison of lifetime incremental cost: utility ratios of surgery relative to failed medical management for the treatment of hip, knee and spine osteoarthritis modelled using 2-year postsurgical values. Can J Surg. 2012;55(3):181-190.
40. Rampersaud YR, Tso P, Walker KR, et al. Comparative outcomes and cost-utility following surgical treatment of focal lumbar spinal stenosis compared with osteoarthritis of the hip or knee, part 2: estimated lifetime incremental cost-utility ratios. Spine J. 2014;14(2):244-254.
41. Tosteson AN, Tosteson TD, Lurie JD, et al. Comparative effectiveness evidence from the spine patient outcomes research trial: surgical versus nonoperative care for spinal stenosis, degenerative spondylolisthesis, and intervertebral disc herniation. Spine (Phila Pa 1976). 2011;36(24):2061-2068.
42. Glassman SD, Polly DW, Dimar JR, Carreon LY. The cost effectiveness of singlelevel instrumented posterolateral lumbar fusion at 5 years after surgery. Spine (Phila Pa 1976). 2012;37(9):769-774.
43. Neumann PJ, Weinstein MC. Legislating against use of cost-effectiveness information. N Engl J Med. 2010;363(16):1495-1497.
44. Nwachukwu BU, Bozic KJ. Updating cost effectiveness analyses in orthopedic surgery: resilience of the $50 000 per QALY threshold. J Arthroplasty. 2015;30(7):1118-1120.
45. Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC. The role of costeffectiveness analysis in health and medicine: Panel on Cost-Effectiveness in Health and Medicine. JAMA. 1996;276(14):1172-1177.
46. Weinstein MC, Skinner JA. Comparative effectiveness and health care spending: implications for reform. N Engl J Med. 2010;362(5):460-465.
47. Salaffi F, Carotti M, Ciapetti A, Gasparini S, Grassi W. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2011;29(4):661-671.
48. Sogaard R, Christensen FB, Videbaek TS, Bunger C, Christiansen T. Interchangeability of the EQ-5D and the SF-6D in long-lasting low back pain. Value Health. 2009;12(4):606-612.